Teleflex (TFX) Hisse Fiyat

Teleflex Inc is primarily active in a variety of industries. As a global provider of medical technology products, the company focuses on healthcare, providing innovative solutions in the areas of surgical and diagnostic devices, anesthesia, and critical care. Teleflex Inc also has a presence in the aerospace industry, supplying specialized control systems and components for aircraft and helicopters. With its diverse portfolio, Teleflex Inc continues to make significant contributions in these sectors, driving advancements and improving patient outcomes in healthcare, while delivering reliable and efficient solutions in the aerospace industry.

The main competitors of Teleflex Inc in the market include Johnson & Johnson, Becton, Dickinson and Company, Medtronic plc, and Smiths Medical.

Teleflex Inc is a renowned company specializing in medical technology. Established in 1943, Teleflex has a rich history rooted in innovation and industry leadership. With headquarters in Wayne, Pennsylvania, the company has expanded globally, offering a diverse portfolio of medical devices that enhance patient care and improve clinical outcomes. Teleflex's dedication to research and development has led to breakthrough solutions in respiratory care, surgical instruments, urology, vascular access, and more. By combining cutting-edge technology with a commitment to quality, Teleflex continues to shape the healthcare industry, providing healthcare professionals with the tools they need to deliver superior patient care.

Teleflex Inc has achieved several significant milestones throughout its history. The company expanded its product portfolio by acquiring Arrow International in 2007, a leading manufacturer of critical care products. In 2011, Teleflex successfully launched the MANTA Vascular Closure Device, revolutionizing the way vascular access sites are closed after procedures. Additionally, the company received FDA clearance for the Teleflex UroLift System in 2013, providing a minimally invasive solution for enlarged prostate patients. In recent years, Teleflex also made significant advancements in its vascular access product line, including the introduction of the ARROW PICC with Chlorag+ard Technology. These achievements highlight Teleflex's continuous commitment to innovation and improving patient outcomes.

Teleflex Inc is primarily present in various countries and regions worldwide. The company has a strong global presence, with operations in North America, Europe, Asia Pacific, and Latin America. Teleflex serves customers and healthcare markets in over 150 countries, providing innovative solutions in medical technology and consumer healthcare. With its diverse portfolio of products and services, Teleflex Inc has established itself as a trusted provider in the medical device industry.

Teleflex Inc represents a set of core values and a corporate philosophy that guide its operations. With a focus on innovation and excellence, the company strives to deliver high-quality medical technology solutions to enhance patient outcomes. Teleflex is committed to providing world-class customer service, ensuring the best user experience for healthcare professionals and patients. With a dedication to integrity, teamwork, and continuous improvement, Teleflex values collaboration, transparency, and ethical conduct in all aspects of its business. By prioritizing customer needs and embracing a culture of innovation, Teleflex aims to make a positive impact in the healthcare industry.

Analistler şu anda Teleflex hissesi için ortalama 153,88 USD hedef fiyat belirliyor (medyan: 156,50 USD); bu, son fiyata göre +23,7 % anlamına gelir. Konsensüs 19 analist notuna dayanır.

Teleflex Analist Fiyat Hedefleri 2026

19 analist şu anda Teleflex hissesini değerlendiriyor: 8 al, 11 tut, 0 sat öneriyor. 2026 için analistler Teleflex şirketinin 2,27 Md USD gelir ve 7,67 USD hisse başına kâr üretmesini bekliyor.

Teleflex Analist Fiyat Hedefleri 2026

Güncel döviz kuruyla Teleflex hissesi 108,49 EUR (124,52 USD) seviyesindedir.

Teleflex hissesi (TFX) 6 borsada işlem görür, bunlar arasında: NYSE (TFX), SIX (Zürich) (TBH.SW), XETRA (TBH.DE), Frankfurt (TBH.F), München (TBH.MU), Düsseldorf (TBH.DU).

Teleflex Inc. is an American company specializing in the manufacturing and selling of medical devices and instruments. It was founded in 1943 and has become a leading provider of medical products. The company divides its business into three main segments: Medical Devices, Anesthesia, and Interventional Medicine. Each segment offers a wide range of products tailored to the specific needs of the healthcare industry. The Medical Devices segment focuses on catheters, leads, drains, and other surgical instruments, while also offering specialized products for cardiology, oncology, and neurology. The Anesthesia segment specializes in products used in anesthesia applications, such as ventilation support devices and block needles. The Interventional Medicine segment focuses on treating and preventing vascular diseases with products like vascular access devices and balloon catheters used in minimally invasive procedures. This segment is the fastest-growing for Teleflex due to increasing demand for minimally invasive treatment methods. Teleflex has built a portfolio of over 30,000 products through acquisitions and internal innovations. Effective management, partnerships with doctors and hospitals, and participation in industry events ensure the company's growth and expansion. In summary, Teleflex Inc. is a company with a wide range of medical products used in various sectors of the healthcare industry. With a global presence and diverse product portfolio, the company can respond to changing customer desires and needs. Through continuous innovation, research, and development, Teleflex aims to revolutionize the healthcare industry and achieve higher levels of effectiveness and efficiency.

beklenen'nin Teleflex hasılatı 2,27 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.

beklenen'nin Teleflex karı 339,29 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.

Teleflex'nin Fiyat/Kazanç (F/K) oranı şu anda 16,24'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Teleflex hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.

Teleflex'nin Fiyat/Satış (F/S) oranı şu anda 2,43'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Teleflex hisse senedinin değerleme metriği olarak hizmet eder.

Teleflex'nin Eulerpool Kalite Puanı 0/10'dur.

Teleflex'nin ISIN'i US8793691069'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.

Teleflex'nin WKN'i 855853'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.

Teleflex'nin ticker'ı TFX'dir. Ticker sembolü, Teleflex hisseleri borsada işlem görmek için kullanılır.

Son 12 ayda Teleflex, 1,36 USD tutarında temettü ödemiştir. Bu, yaklaşık 1,09 % temettü verimine karşılık gelmektedir. Gelecek 12 ayda Teleflex, 1,36 USD tutarında temettü ödeyeceği beklenmektedir.

Teleflex'nin mevcut temettü getirisi 1,09 %'dir.

Teleflex temettü öder; dağıtım Kasım, Mart, Mayıs, Ağustos aylarında yapılır.

Teleflex son 36 yıl boyunca her yıl temettü ödemiştir.

Gelecek 12 ayda 1,36 USD tutarında temettü beklenmektedir. Bu, 1,09 % temettü verimine karşılık gelmektedir.

Teleflex, 'Sağlık' sektörüne atanmıştır.

2025 yılında Teleflex tarafından 1,36 USD temettü olarak dağıtılmıştır.

Teleflex'un temettüleri USD cinsinden dağıtılır.